Mouth Ulcer Treatment Market Report by Formulation, Drug Class, Indication, and Region 2024-2032
세계 구내염 치료 시장 규모는 2023년 19억 달러에 달했습니다. 향후 IMARC Group은 2032년까지 시장이 2024-2032년 사이 2.9%의 연평균 성장률(CAGR)로 2032년까지 25억 달러에 달할 것으로 예상하고 있습니다.
구내염은 입안에 생기는 고통스러운 궤양입니다. 구내염은 통증을 유발하고 먹고 마시거나 양치질하는 데 어려움을 겪을 수 있습니다. 불편하긴 하지만 대부분의 구내염은 보통 무해하며 2-3일에서 2주 이내에 자연 치유됩니다. 구내염은 보통 입안의 뺨, 입술, 혀에 생기는 원형 또는 타원형의 궤양입니다. 구내염의 색은 흰색, 빨간색, 노란색, 회색이며 때로는 부어 오를 수 있습니다.
구내염을 유발하는 주요 요인으로는 스트레스, 감염, 부상, 알레르기, 정크푸드, 흡연 등 건강에 해로운 생활습관 등이 있습니다. 구내염 발병률 증가에 힘입어 구내염 치료 시장도 높은 성장세를 보이고 있습니다. 최신 치료법에 대한 인식 증가, 노인 인구의 증가, 빠른 치료와 사용이 편리한 제품의 가용성 등의 요인도 시장에 긍정적인 영향을 미치고 있습니다.
본 보고서에서 다루는 주요 질문들
- 세계 구내염 치료 시장은 지금까지 어떻게 성장해 왔으며, 향후 몇 년 동안 어떻게 성장할 것인가?
- 세계 구내염 치료 산업의 주요 지역 시장은?
- COVID-19가 전 세계 구내염 치료 산업에 미치는 영향은?
- 세계 구내염 치료 제형별 시장 현황은?
- 약물 종류별 구내염 치료 세계 시장 현황은?
- 적응증별 구내염 치료 세계 시장 현황은?
- 구내염 치료 세계 시장 가치사슬의 다양한 단계는 무엇인가?
- 구내염 치료 세계 시장에서의 주요 촉진요인과 과제는 무엇인가?
- 세계 구내염 치료 시장 구조와 주요 진출 기업은?
- 세계 구내염 치료 시장의 경쟁 정도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 구내염 치료 세계 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 내역 : 제형별
- 시장 내역 : 약제 클래스별
- 시장 내역 : 적응증별
- 시장 내역 : 지역별
- 시장 예측
- SWOT 분석
- 밸류체인 분석
- 원재료 조달
- 제조
- 마케팅
- 유통
- 소매
- 최종 용도
- Porter's Five Forces 분석
- 개요
- 구매자의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 참여업체의 위협
- 대체품의 위협
제6장 시장 내역 : 제형별
제7장 시장 내역 : 약제 클래스별
- 코르티코스테로이드
- 마취제
- 진통제
- 항균제
- 항히스타민제
제8장 시장 내역 : 적응증별
제9장 시장 내역 : 지역별
- 북미
- 유럽
- 아시아태평양
- 중동 및 아프리카
- 라틴아메리카
제10장 경쟁 상황
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Blistex Inc.
- Church & Dwight Co., Inc.
- 3M Company
- Colgate-Palmolive Company
- GSK plc.
- Bristol-Myers Squibb Company
- Pfizer Inc.
ksm
The global mouth ulcer treatment market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032.
Mouth ulcers are painful sores that can appear in the mouth. They can be painful and can make it uncomfortable for an individual to eat, drink or brush his/her teeth. While they're uncomfortable, most mouth ulcers are usually harmless and can clear up by themselves within a couple of days to a fortnight. They are normally round or oval sores that usually appear inside the mouth on the cheeks, lips and tongue. Mouth ulcers can be white, red, yellow or grey in colour and swollen.
Some of the major factors which are leading to mouth ulcers include stress, infection, injury, allergy, unhealthy lifestyles such as high consumption of junk foods and tobacco, etc. Catalyzed by a rising incidence of mouth ulcers, the market for mouth ulcer treatment is also undergoing strong growth. Factors such as rising awareness on modern treatment options, increasing geriatric population, availability of rapid healing and easy to use products, etc., are also creating a positive impact on the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global mouth ulcer treatment market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on formulation, drug class and indication.
Breakup by Formulation:
Gel
Spray
Mouthwash
Lozenges
Based on the formulation, the market has been segmented as gel, spray, mouthwash and lozenges.
Breakup by Drug Class:
Corticosteroids
Anesthetics
Analgesics
Antimicrobials
Antihistamines
On the basis of drug class, corticosteroids represents the largest segment. Other segments include anesthetics, analgesics, antimicrobials and antihistamines.
Breakup by Indication:
Aphthous Stomatitis
Oral Lichen Planus
Others
Based on the indication, the market has been segmented into aphthous stomatitis, oral lichen planus and others.
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being Blistex Inc, Church & Dwight Co. Inc., 3M Company, Colgate-Palmolive Company, GSK plc., Bristol-Myers Squibb Company, and Pfizer Inc.
This report provides a deep insight into the global mouth ulcer treatment market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the mouth ulcer treatment industry in any manner.
Key Questions Answered in This Report:
- How has the global mouth ulcer treatment market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global mouth ulcer treatment industry?
- What has been the impact of COVID-19 on the global mouth ulcer treatment industry?
- What is the breakup of the global mouth ulcer treatment market on the basis of formulation?
- What is the breakup of the global mouth ulcer treatment market on the basis of drug class?
- What is the breakup of the global mouth ulcer treatment market on the basis of indication?
- What are the various stages in the value chain of the global mouth ulcer treatment market?
- What are the key driving factors and challenges in the global mouth ulcer treatment market?
- What is the structure of the global mouth ulcer treatment market and who are the key players?
- What is the degree of competition in the global mouth ulcer treatment market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Mouth Ulcer Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Formulation
- 5.5 Market Breakup by Drug Class
- 5.6 Market Breakup by Indication
- 5.7 Market Breakup by Region
- 5.8 Market Forecast
- 5.9 SWOT Analysis
- 5.9.1 Overview
- 5.9.2 Strengths
- 5.9.3 Weaknesses
- 5.9.4 Opportunities
- 5.9.5 Threats
- 5.10 Value Chain Analysis
- 5.10.1 Raw Material Procurement
- 5.10.2 Manufacturing
- 5.10.3 Marketing
- 5.10.4 Distribution
- 5.10.5 Retail
- 5.10.6 End-Use
- 5.11 Porters Five Forces Analysis
- 5.11.1 Overview
- 5.11.2 Bargaining Power of Buyers
- 5.11.3 Bargaining Power of Suppliers
- 5.11.4 Degree of Competition
- 5.11.5 Threat of New Entrants
- 5.11.6 Threat of Substitutes
6 Market Breakup by Formulation
- 6.1 Gel
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Spray
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Mouthwash
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Lozenges
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Drug Class
- 7.1 Corticosteroids
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Anesthetics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Analgesics
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Antimicrobials
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Antihistamines
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Indication
- 8.1 Aphthous Stomatitis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Oral Lichen Planus
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Europe
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Asia Pacific
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Middle East and Africa
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Latin America
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Competitive Landscape
- 10.1 Market Structure
- 10.2 Key Players
- 10.3 Profiles of Key Players
- 10.3.1 Blistex Inc.
- 10.3.2 Church & Dwight Co., Inc.
- 10.3.3 3M Company
- 10.3.4 Colgate- Palmolive Company
- 10.3.5 GSK plc.
- 10.3.6 Bristol-Myers Squibb Company
- 10.3.7 Pfizer Inc.
